Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients

Clinical Biochemistry

Volumn 44, Issue 16, 2011, Pages 1280-1283

  De Luis, D A ^a   Gonzalez Sagrado, M ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a   Primo, D ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Females; Metabolic syndrome; Obesity; Resistin

Indexed keywords

C REACTIVE PROTEIN; RESISTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FATS; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RESISTIN; WAIST CIRCUMFERENCE;

EID: 80054070087     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.002     Document Type: Article

References (31)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
2. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
3. Chen C.C., Li T.C., Li C.I., Liu C.S., Wang H.J., Lin C.C. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005, 54:471-475.
4. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2457.
5. de Luis D.A., Gonzalez Sagrado M., Conde R., Aller R., Izaola O., de la Fuente B. Relation of resistin with cardiovascular risk factors, insulin resistance and inflammation in naive diabetes obese patients. Diabetes Res Clin Pract 2010, 89:110-114.
6. Utzschneider K.M., Carr D.B., Tong J., Wallace T.M., Hull R.L., Zraika S., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005, 48:2330-2333.
7. Matsuda M., Shimomura I., Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
8. Steppan C., Lazar M. The current biology of resistin. J Intern Med 2004, 255:439-447.
9. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004, 53:1937-1941.
10. Pagano C., Marin O., Calcagno A., Schiappelli P., Pilon C., Milan G., et al. Increased serum resistin in adults with Prader Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005, 90:4335-4340.
11. Burnett M.S., Devaney J.M., Adenika R.J., Lindsay R., Howard B.V. Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J Clin Endocrinol Metab 2006, 91:64-68.
12. Zou C.C., Liang L., Hong F., Fu J.F., Zhao Z.Y. Serum adiponectin, resistin levels and non alcoholic fatty liver disease in obese children. Endocr J 2005, 52:519-524.
13. De Luis D.A., Gonzalez Sagrado M., Conde R., Aller R., Izaola O., Perez J.L., et al. Reltion of resistin levels with cardiovascular risk factors and insulin rsistante in non-diabetic obese patients. Diabetes Res Clin Pract 2009, 84:174-178.
14. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
15. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A. Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-414.
16. Lukaski H., Johson P.E. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr Apr 1985, 41(4):810-817.
17. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
18. Azuma K., Katsukawa F., Oguchi S., Murata M., Yamazaki H., Shimada A., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003, 11:997-1001.
19. McTernan P.G., Fisher F.M., Valsamakis G., Chetty R., Harte A., McTernan C.L., et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003, 88:6098-6106.
20. Youn B.-S., Yu K.-Y., Park H.J., Lee N.S., Min S.S., Youn M.Y., et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004, 89:150-156.
21. Osawa H., Onuma H., Ochi M., Murakami A., Yamauchi J., Takasuka T., et al. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 2005, 335:596-602.
22. Savage D.B., Sewter C.P., Klenk E.S., Segal D.G., Vidal-Puig A., Considine R.V., et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 2001, 50:2199-2202.
23. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
24. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2457.
25. Fujinami A., Obayashi H., Ohta K., Ichimura T., Nishimura M., Matsui H., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004, 339:57-63.
26. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004, 314:415-419.
27. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005, 174:5789-5795.
28. Chen C.C., Li T.C., Li C.I., Liu C.S., Wang H.J., Lin C.C. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 2005, 54:471-475.
29. Sato N., Kobayashi K., Inoguchi T., Sonoda N., Imamura M., Sekiguchi N., et al. Adenovirusmediated high expression of resistin causes dyslipidemia in mice. Endocrinology 2005, 146:273-279.
30. Osawa H., Ochi M., Tabara Y., Kat K., Yamauchi J., Takata Y., et al. Serum resistin is positively correlated with the acumulation of metabolic síndrome factors in type 2 diabetes. Clin Endocrinol 2008, 69:74-80.
31. Menzaghi C., Coco A., Salvemini L., Thompson R., De Cosmo S., Doria A., et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 2006, 91:2792-2795.